Abizer Gaslightwala

Insider Reports History

Entity
Individual
Location
Akari Therapeutics, Plc, 22 Boston Wharf Road Fl 7, Boston, MA
Signature
/s/ Torsten Hombeck, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Abizer Gaslightwala:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 181K $203K $1.12 Mar 20, 2025 Direct
Akari Therapeutics Plc Director Series A Warrants (Right to Buy) 134K $150K $1.12 Mar 6, 2025 Direct
Akari Therapeutics Plc Director Series B Warrants (Right to Buy) 134K $150K $1.12 Mar 6, 2025 Direct
Akari Therapeutics Plc Director American Depository Shares representing Ordinary Shares 47.5K $58K $1.22 Jan 10, 2025 Direct
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 71.7M $43K $0.00 Jan 3, 2025 Direct
Akari Therapeutics Plc Director Stock Option (Right to Buy) 600K Mar 20, 2025 Direct

Insider Reports Filed by Abizer Gaslightwala

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKTX Akari Therapeutics Plc Mar 20, 2025 2 $0 4 Mar 24, 2025 Director
AKTX Akari Therapeutics Plc Mar 6, 2025 3 $450K 4 Mar 10, 2025 Director
AKTX Akari Therapeutics Plc Jan 10, 2025 1 $14.2K 4/A Feb 7, 2025 Director
AKTX Akari Therapeutics Plc Jan 3, 2025 1 $1.03K 4 Jan 7, 2025 Director
AKTX Akari Therapeutics Plc Dec 27, 2024 1 $20K 4 Dec 30, 2024 Director
AKTX Akari Therapeutics Plc Dec 26, 2024 1 $15K 4 Dec 27, 2024 Director
AKTX Akari Therapeutics Plc Dec 16, 2024 0 $0 3 Dec 26, 2024 Director